{
    "clinical_study": {
        "@rank": "26635", 
        "arm_group": {
            "arm_group_label": "Directional lead", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to provide proof-of-concept that directional stimulation, in an\n      intraoperative setting, is perceivable in a subject and is different from omnidirectional\n      stimulation. The tests will be performed using a dedicated DBS lead connected to external\n      neurostimulator."
        }, 
        "brief_title": "Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Parkinson's Disease", 
            "Essential Tremor"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Parkinson Disease", 
                "Tremor", 
                "Essential Tremor"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is indicated to undergo DBS for Parkinson's disease or Essential Tremor\n             according to criteria of the Study site\n\n          -  For Parkinson Disease:\n\n               -  Person is between 18 and 75 years of age\n\n               -  Established diagnosis of idiopathic Parkinson's disease with progression of\n                  symptoms for a minimum of 2 years.\n\n               -  Person has a history of at least 30% improvement on the Unified Parkinson's\n                  Disease Rating Scale with therapy in L-dopa (levodopa)\n\n               -  Weak control of symptoms by dopaminergic therapy (off phenomenon, fluctuations\n                  on / off, dyskinesia on)\n\n          -  For Essential Tremor:\n\n               -  Person is between 18 and 80 years of age\n\n               -  Established diagnosis of Essential Tremor for a minimum of 2 years\n\n               -  Functional disability due to tremor was not adequately controlled by medication\n                  for at least 3 months prior to implant.\n\n          -  Person has given his/her written consent\n\n        Exclusion Criteria:\n\n          -  Person suffering from an active major psychiatric disorder\n\n          -  Mattis Dementia Rating Scale score <130 or otherwise not capable of discernment\n\n          -  Presence of major co-morbidity or medical condition that may affect participation to\n             the study\n\n          -  Presence of an electrical or electromagnetic implant (e.g., cochlear implant,\n             pacemaker)\n\n          -  Person with a previous surgery for the treatment of Parkinson's disease or Essential\n             Tremor\n\n          -  Person with a previous brain ablation procedure\n\n          -  Person who suffers from epilepsy\n\n          -  Person who is pregnant: a pregnancy test will be performed in women of childbearing\n             age\n\n          -  Person with coagulopathies\n\n          -  Abuse of drugs or alcohol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "13", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764815", 
            "org_study_id": "KEK 072-12", 
            "secondary_id": "CIV-12-08-008482"
        }, 
        "intervention": {
            "arm_group_label": "Directional lead", 
            "description": "Test phase will be performed intra-operatively, prior to chronic lead implant", 
            "intervention_name": "directSTN Acute lead connected to external neurostimulator", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bern", 
                    "country": "Switzerland", 
                    "zip": "3030"
                }, 
                "name": "Inselspital University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation Leads for the Treatment of Movement Disorders", 
        "overall_official": {
            "affiliation": "Inselspital, Bern University Hospital", 
            "last_name": "Claudio Pollo, PD, Dr. med", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "A therapeutic window is defined as the difference between the electrical current threshold at which a desired therapeutic effect is obtained and the current threshold at which side effects appear.", 
            "measure": "Measurement of the therapeutic window's boundaries when stimulating in specific angular directions, and comparison to those obtained when stimulating in all directions.", 
            "safety_issue": "No", 
            "time_frame": "up to one hour during surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764815"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The electrical integrity of the device will be measured before and after its use, to confirm that it was functional throughout the test phase.", 
            "measure": "Electrical functionality of the study device during the test phase", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "Aleva Neurotherapeutics SA", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aleva Neurotherapeutics SA", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}